A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Completed · Phase 1

Conditions studied: Monitored Anesthesia Care

In brief

The purpose of this study is to explore the pharmacokinetics (PK) and pharmacodynamics (PD) of LUSEDRA® administered as a continuous infusion or bolus compared with continuous infusion of propofol injectable emulsion.

Key facts

Study ID

NCT01308541

Run by

Eisai Inc.

People needed

20

Starts

2011-01-01

Expected to finish

2011-08-01

Last updated by the study team

2015-11-03

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Utah — Salt Lake City Utah, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.